Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-4-15
|
pubmed:abstractText |
Epstein-Barr virus nuclear antigen 1 (EBNA 1) has been shown to be a sequence-specific DNA binding protein that is required for the replication of episomal elements carrying the viral origin of DNA replication, oriP, as well as for the activation of a specific transcriptional enhancer. We have constructed and analyzed a series of deletion and nonsense mutants in a cloned copy of the EBNA 1 gene and have tested mutant peptides for the ability (a) to bind to a synthetic oligonucleotide containing a consensus EBNA 1 binding site, (b) to activate the EBNA 1-specific enhancer, and (c) to drive replication of an oriP-bearing plasmid in a transient replication assay. The presence of a DNA binding domain in the carboxy-terminal third of the protein was confirmed. Interestingly, neither the acidic tail nor the Gly-Ala copolymer of EBNA 1 contributes significantly to binding. In addition to sequences in the carboxy-terminal portion of the protein, our data indicate that sequences in the amino-terminal portion of the polypeptide affect the binding of EBNA 1 to its target sequence. Further, we show that EBNA 1 binds to its recognition sequence as a dimer. Results of transient expression assays indicate that the ability of EBNA 1 species to activate the transcriptional enhancer and to drive the replication of oriP plasmids is directly dependent on the ability of the polypeptides to bind to the EBNA 1 consensus binding sequence.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Epstein-Barr Virus Nuclear Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Oligodeoxyribonucleotides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0042-6822
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
187
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
591-603
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1312270-Antigens, Viral,
pubmed-meshheading:1312270-Base Sequence,
pubmed-meshheading:1312270-Cloning, Molecular,
pubmed-meshheading:1312270-DNA Mutational Analysis,
pubmed-meshheading:1312270-DNA Replication,
pubmed-meshheading:1312270-DNA-Binding Proteins,
pubmed-meshheading:1312270-Enhancer Elements, Genetic,
pubmed-meshheading:1312270-Epstein-Barr Virus Nuclear Antigens,
pubmed-meshheading:1312270-Gene Expression Regulation, Viral,
pubmed-meshheading:1312270-Herpesvirus 4, Human,
pubmed-meshheading:1312270-Oligodeoxyribonucleotides,
pubmed-meshheading:1312270-Plasmids,
pubmed-meshheading:1312270-Regulatory Sequences, Nucleic Acid,
pubmed-meshheading:1312270-Structure-Activity Relationship,
pubmed-meshheading:1312270-Transcription, Genetic,
pubmed-meshheading:1312270-Transcriptional Activation
|
pubmed:year |
1992
|
pubmed:articleTitle |
DNA binding activity is required for EBNA 1-dependent transcriptional activation and DNA replication.
|
pubmed:affiliation |
Department of Biology, Northeastern University, Boston, Massachusetts 02115.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|